KalVista Pharmaceuticals, Inc. - COM (KALV)

Q1 2024 13F Holders as of 3/31/2024

Type / Class
Equity / COM
Number of holders
128
Total Shares
47M
Shares change
+9.99M
Total reported value, excl. options
$557M
Value change
+$118M
Put/Call ratio
1.14
Number of buys
77
Number of sells
-47
Price
$11.86
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.